GT Biopharma stock forecast
GT Biopharma (OXI) Stock Forecast & Price Target
OXI Analyst Ratings
OXI Stock 12 Month Forecast
Average Price Target
EUR 2.69▼(-97.75% Downside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Jonathan Aschoff | Roth MKM | EUR 2.69 | buy | -97.75%Downside | Reiterated | 08/17/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Jonathan AschoffRoth MKM | BuyReiteratedEUR 2.69 | 08/17/26 | -97.75%Downside |
Best Analysts Covering GT Biopharma
Copying Jonathan Aschoff's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -20.77% per trade.
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -69.58% per trade.
Copying Jonathan Aschoff's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -76.52% per trade.
OXI Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 1 | 1 | 1 | 0 |
In the current month, OXI has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OXI average Analyst price target in the past 3 months is 2.69.
OXI Financial Forecast
OXI Sales Forecast
Next quarter’s sales forecast for OXI is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
